Pharmaceutics (Nov 2022)

Dehydroepiandrosterone Cocrystals with Improved Solubility and Bioavailability

  • Yihua Jiang,
  • Yinxiang Cheng,
  • Mengyuan Xia,
  • Bingrui Zhang,
  • Qiaoce Ding,
  • Liye Lu,
  • Jian-Rong Wang,
  • Xuefeng Mei

DOI
https://doi.org/10.3390/pharmaceutics14112478
Journal volume & issue
Vol. 14, no. 11
p. 2478

Abstract

Read online

Dehydroepiandrosterone (DHEA) is an FDA-approved food supplement used as an assisted reproductive sex hormone. The bioavailability is severely limited by its poor solubility (23 µg/mL). Herein, we aimed to modulate its solubility through cocrystallization. Eight cocrystals of DHEA with pyrocatechol (CAT), hydroquinone (HQ), resorcinol (RES), phloroglucinol (PG), 1,5-dihydroxy naphthalene (DHN), p-hydroxybenzoic acid (PHBA), gallic acid (GA), and 5-hydroxyisophthalic acid (5HIPA) were designed and synthesized. Some basic characterization tools, including powder X-ray diffraction, thermogravimetric analysis, differential scanning calorimetry, and Fourier transform infrared spectroscopy, were also applied in our work for basic analyses of cocrystals. It is indicated that DHEA-GA exhibits its superiority in dissolution and pharmacokinetic behaviors. While the area under the curve values of DHEA-GA is improved at the ratio of 2.2, the corresponding bioavailability of DHEA is expected to be accordingly increased.

Keywords